Mark P. Murphy
- Co-authors
- Britta StordalRonald LagoeNoel G. McElvaneyEmma CaraherEmer P. ReevesOliver J. McElvaneyOrla M. KeaneOisín F. McElvaney
- Topics
- Protease and Inhibitor Mechanisms (10 papers)Peptidase Inhibition and Analysis (7 papers)Cystic Fibrosis Research Advances (7 papers)
- Journals
- The Journal of ImmunologyAmerican Journal of Respiratory and Critical Care MedicineScientific Reports
- Partner nations
- IrelandUnited StatesUnited Kingdom
In The Last Decade
Mark P. Murphy
26 papers receiving 418 citations
Peers
Comparison fields: 5 of 89
- Pulmonary and Respiratory Medicine 157
- Molecular Biology 102
- Cancer Research 65
- Oncology 57
- Immunology 52
Countries citing papers authored by Mark P. Murphy
This map shows the geographic impact of Mark P. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Murphy more than expected).
Fields of papers citing papers by Mark P. Murphy
This network shows the impact of papers produced by Mark P. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Murphy. The network helps show where Mark P. Murphy may publish in the future.
Co-authorship network of co-authors of Mark P. Murphy
This figure shows the co-authorship network connecting the top 25 collaborators of Mark P. Murphy. A scholar is included among the top collaborators of Mark P. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark P. Murphy. Mark P. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 21 | |
| 4 | 56 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 14 | |
| 9 | 21 | |
| 10 | 27 | |
| 11 | 16 | |
| 12 | 17 | |
| 13 | 11 | |
| 14 | 31 | |
| 15 | 3 | |
| 16 | 28 | |
| 17 | 12 | |
| 18 | 44 | |
| 19 | 53 | |
| 20 | 24 |
About Mark P. Murphy
Mark P. Murphy is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Hematology, having authored 29 papers that have together received 425 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (10 papers), Peptidase Inhibition and Analysis (7 papers) and Cystic Fibrosis Research Advances (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (157 citations), Cancer Research (65 citations) and Agronomy and Crop Science (40 citations). Mark P. Murphy has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Britta Stordal, Ronald Lagoe, Noel G. McElvaney, Emma Caraher, Emer P. Reeves, Oliver J. McElvaney, Orla M. Keane, Oisín F. McElvaney, Finola C. Leonard and Tomás P. Carroll. Their work appears in journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.